Top Ten articles in the Pharma Industry this week
September 16, 2016Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto
As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
Teva and Intel team up to tackle Huntington’s with wearable tech
September 16, 2016Medical Communications Huntington's, Intel, Teva, wearable tech
Israeli pharma firm Teva is joining forces with technology giant Intel to tackle the debilitating disease Huntington’s with cutting-edge wearable …
Dechra signs £31 million acquisition
September 16, 2016Medical Communications Apex Laboratories, Dechra, acquisition
Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …
Novo Nordisk’s diabetes drug “significantly reduced’ cardiovascular risk
September 16, 2016Medical Communications Novo Nordisk, diabetes, semaglutide
Novo Nordisk has announced that its diabetes drug semaglutide “significantly reduced” the risk of major cardiovascular events at the 52nd …
Cirrus – a new name for specialist artwork services
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Multi Packaging Solutions (“MPS”), a global leader in value-added print and packaging solutions for the pharmaceutical, healthcare and FMCG sectors, …
New immunology and inflammation research global head and North American CSO for Sanofi
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, appointment
Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …
Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment
Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …
Allergan snaps up Vitae Pharma for $639 million
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition
Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …
UK Biopharma and life after Brexit
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …
Mylan CEO to appear before US congress over EpiPen scandal
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Hilary Clinton, Mylan, epipen
Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …
GSK’s shingles vaccine tops MSD rival in Ph III testing
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
GlaxoSmithKline’s shingles vaccine Shingrix has topped rival MSD treatment Zostavax as it is shown to remain effective in elderly patients …
EU approval for Eisai kidney cancer treatment
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, Eisai, Kisplyx, Lenvima, everolimus
The European Commission has approved the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma (RCC) following …
Bayer acquires Monsanto in largest-ever deal by a German company
September 14, 2016Business Services, Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto
Bayer and Monsanto have signed a definitive merger agreement under which the German drugmaker will acquire the US agricultural group …
Sanofi reveals promising data for FDA-delayed diabetes drug
September 14, 2016Research and Development, Sales and Marketing FDA, Lantus, Sanofi, iglarlixi
Sanofi has announced new Phase III data for its IGlarLixi combination drug for the treatment of diabetes, showing it could …
Bayer raises bid yet again to finalise Monsanto deal
September 14, 2016Manufacturing and Production, Research and Development, Sales and Marketing
Bayer has taken yet another step in its dedicated efforts to acquire Monsanto as it raises its offer to $129 …
Roche’s Ocrevus more effective than Merck’s Rebif, company claims
September 14, 2016Research and Development Merck, Ocrevus, Rebif, Roche, multiple sclerosis
Roche has announced new results from the Phase III studies of investigational medicine Ocrevus (ocrelizumab) studying relapsing multiple sclerosis (RMS) …
Takeda reportedly sets $15bn on US acquisitions
September 14, 2016Manufacturing and Production, Research and Development Takeda, acquisitions
Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …
Novartis joins $17m funding of chronic inflammatory disease startup
September 14, 2016Research and Development Fountain Healthcare, Novartis, start up financing
Novartis was one of the co-leaders in the $17million series A financing of Irish startup in the development of chronic …
ClinTec appoints Rick Farris as executive vice president of North American Operations
September 13, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ClinTec, appointment
Clinical research organisation ClinTec has announced the expansion of its US management team with the selection of Rick Farris as …
Eisai reveals new long-term seizure control data at ECE 2016
September 13, 2016Manufacturing and Production, Research and Development Eisai, epilepsy
Eisai has revealed new data on long-term seizure control in different seizure types at the 12th European Congress on Epileptology …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
